Search Results - "Muston, D."

A model of the natural history of screen-detected prostate cancer, and the effect of radical treatment on overall survival by PARKER, C, MUSTON, D, MELIA, J, MOSS, S, DEARNALEY, D

“…The lead time and over-detection associated with prostate-specific antigen (PSA) screening, and generational improvements in all-cause mortality, make prostate…”
Get full text

PIH32 The Impact of Periods on Women's Quality of Life in Women Reporting a Problem by Pumford, N, Muston, D, Wade, A, Crawford, G, Young, D

Get full text

EE378 Targeted Literature Review of Non-Payer Costing in Societal-Perspective Oncology Cost Effectiveness Models by Beaulieu, E., Bozkaya, D., Muston, D.

Get full text

Indirect Cost Burden Attributable to Locally Advanced Head and Neck Squamous Cell Carcinoma in the United States by Bensimon, A.G., Muston, D., Ramakrishnan, K., Zhang, S., Black, C.

Get full text

EE231 Calculating the Indirect Cost of Disease Recurrence and Subsequent Premature Mortality in Patients Diagnosed with Early-Stage Hepatocellular Carcinoma (HCC) in the United States (US) by Ektare, V, Hegde, S, Snedecor, SJ, Muston, D

Get full text

Budget Impact of Keytruda for the Treatment of Patients with Recurrent or Metastatic (R/M) and Locally Advanced (LA) Cutaneous Squamous Cell Carcinoma (cSCC) in the United States by Li, X.J., Muston, D., Ramakrishnan, K., Black, C., Hughes, R., Weston, G., Lucherini, S.

“…cSCC is a type of non-melanoma skin cancer and represents 20% of skin cancer deaths. When not cured by local therapy, cSCC is associated with mortality rates…”
Get full text

EE673 Cost-Effectiveness Analysis of Pembrolizumab for First-Line Treatment in Patients With Persistent, Recurrent, and Metastatic Cervical Cancer in the United States: Results From the Final Analysis of Trial by Swami, S., Hale, O., Thornton, I., Muston, D., Monberg, M.J., Monk, B.J.

Get full text

PCN72 Biomarker Testing to Guide Cost Effective Use of PARPi in Patients with Newly Diagnosed Ovarian Cancer by Muston, D., Hettle, R., McLaurin, K., Fan, L., Monberg, M.J.

Get full text

The Effects of Antimuscarinic Treatments in Overactive Bladder: An Update of a Systematic Review and Meta-Analysis by Chapple, Christopher R, Khullar, Vik, Gabriel, Zahava, Muston, Dominic, Bitoun, Caty Ebel, Weinstein, David

“…Abstract Context Antimuscarinic agents are currently the first-line pharmacotherapy for overactive bladder. Objectives A systematic review published in 2005…”
Get full text

PT33 Cost-Effectiveness of Pembrolizumab Plus Chemotherapy, With or Without Bevacizumab for the First-Line Treatment of PD-L1-Positive Patients With Persistent, Recurrent, or Metastatic Cervical Cancer in France by Ray-Coquard, I., Pautier, P., Muston, D., Monberg, M.J., Swami, S., Chaker, O., Bensimon, L., Lange, S., Kulakova, M., Durand Zaleski, I., Marié, L.

Get full text

PCN70 HEALTHCARE RESOURCE UTILIZATION AND COSTS IN METASTATIC PANCREATIC CANCER: A SYSTEMATIC LITERATURE REVIEW by Joo, S., Amin, S., Yoo, H.K., Muston, D., Kulkarni, A.S., Esposito, P., Kaur, S., Sharma, S.

Get full text

622P Exploring the impact of treatment switching on the interim overall survival (OS) results of the PROfound study by Agarwal, N., Evans, R., Abrams, K., Dequen-O'Byrne, P., McCrea, C., Muston, D., Gresty, C., Ghate, S., Fan, L., Hettle, R., Hawkins, N.

Get full text

PCN96 US COST-EFFECTIVENESS OF PEMBROLIZUMAB COMPARED TO REGORAFENIB AND CABOZANTINIB IN SECOND LINE TREATMENT OF ADVANCED HEPATOCELLULAR CARCINOMA by Upadhyay, N., Mistry, R., Suri, G., Phelps, H., Guest, S., Muston, D.

Get full text

PCN107 COST COMPARISON OF ADVERSE EVENT MANAGEMENT WITH POLY (ADP-RIBOSE) POLYMERASE (PARP) INHIBITORS (PARPI) IN THE MAINTENANCE TREATMENT OF ADVANCED OVARIAN CANCER by Hettle, R., McLaurin, K., Mihai, A., Poeton, A., Muston, D., Lopez-Acevedo, M., Maguire, P., Wynne, T.

Get full text

A Systematic Review and Network Meta-Analysis of Intravitreal Aflibercept Injection Versus other Treatments For Macular Edema Secondary to Central Retinal Vein Occlusion by Krivasi, T, Guillermin, A, Muston, D, Lloyd, A

Get full text

PSS4 - A Systematic Review and Network Meta-Analysis of Intravitreal Aflibercept Injection Versus other Treatments For Macular Edema Secondary to Central Retinal Vein Occlusion by Krivasi, T, Guillermin, A, Muston, D, Lloyd, A

Get full text

PMC21 COST-EFFECTIVENESS SENSITIVITY TO COST-EFFECTIVENESS CORRELATION: A SIMULATION STUDY by Muston, D

Get full text

PHP34 EXAMINING INCENTIVES FOR SUBGROUPING IN NICE SUBMISSIONS by Muston, D

Get full text

PMC8 SYSTEMATIC REVIEW RELIABILITY: EFFICACY OF TWO INDEPENDENT REVIEWERS AND TWO-STEP REVIEWS by Pietri, G, Muston, D

Get full text

PMC63 SYSTEMATIC REVIEW RELIABILITY: SENSITIVITY AND SPECIFICITY OF ONEVS.TWO REVIEWS by Muston, D, Alnwick, K

Get full text